August 26, 2019 by Noah Blaine Jim Cramer: Here’s How Amgen’s Otezla Deal Impacts Bristol-Myers-Celgene Merger Jim Cramer breaks down Amgen’s deal to buy Otezla’s rights from Celgene. source https://finance.yahoo.com/m/a1a302ee-403c-3932-b2f2-4787ed1b775a/jim-cramer%3A-here%27s-how.html?.tsrc=rss Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Like Loading... Related
blaineonline.finance.blog 